Table 2.
Selected MicroRNAs Involved in Sepsis
| MicroRNAs | Expression in Sepsis | Key Points of Investigation | Model (In Vitro, In Vivo, Human) | Sample Type | Sample Size | Ref. |
|---|---|---|---|---|---|---|
| miR-150 | down | miR-150 levels in both leukocytes and plasma correlated with the severity of sepsis and could be used as a marker of early sepsis | humans | plasma, leukocytes | 8 | 140 |
| plasma ratio of levels of miR-150/IL-18 could be used for assessing the severity of sepsis | ||||||
| miR-125b | down | polymicrobial sepsis (CLP) decreased miR-125b levels in circulation and in myocardium | mice | heart | – | 231 |
| miR-205b | down | serum miR-205b concentrations were decreased in the LPS group compared to control group, but in lungs, spleen, and liver the decrease was not significant | mice | serum, organs | – | 232 |
| miR-23a-5p | down | serum miR-23a-5p was increased after LPS injection | rats | serum, lung tissues | – | 102 |
| miR-21-3p | up | miR-21-3p controls sepsis-related cardiac dysfunction through modulating SORB | in vivo | plasma | 46 | 233 |
| miR-23b | down | LPS downregulates miR-23b expression in human vascular endothelial cells (VECs); upregulation of miR-23b inhibited the expression of NF-κB, TNF-α, IL-6, ICAM-1, E-selectin and vascular cell adhesion molecule-1 (VCAM-1) | in vitro | vascular endothelial cells | – | 234 |
| miR-375 | down | miR-375 can block the JAK2-STAT3 pathway and modulate the level of miR-21 involved in the regulation of late-stage sepsis | in vivo | blood | 33 | 235 |
| miR-342-5p | down | – | humans | plasma, leukocytes | 8 | 140 |
| miR-182 | down | – | humans | plasma, leukocytes | 8 | 140 |
| miR-146a | down | – | humans | serum | 50 + 30 (SIRS) | 24 |
| miR-223 | down | – | humans | serum | 50 + 30 (SIRS) | 24 |
| miR-130a | down | – | humans | PBMCs | 60 | 149 |
| miR-31 | down | miR-31 downregulation in CD4+ T cells contributes to immunosuppression in sepsis patients via promoting TH2 skewing | humans | T cells | 23 | 236 |
| miR-15a | down | – | humans | plasma | 62 | 30 |
| miR-27a | down | miR-34a, miR-15a, and miR-27a are correlated with shock development in severe sepsis patients; they also target cell cycle regulation, apoptosis, cell layer permeability, and inflammatory pathways | humans | plasma | 62 | 30 |
| miR-25 | down | a correlation between levels of miR-25 and the severity of sepsis was observed; surviving patients had higher levels of this biomarker compared with non-surviving subjects; decreased levels of miR-25 were associated with the concentrations of oxidative stress indicators in sepsis | humans | blood | 70 + 30 (SIRS) | 28 |
| miR-146a, miR-181a, miR-584 | down | – | humans | PBMCs | 32 | 80 |
| miR-146a | down | miR-146a gene polymorphism rs2910164 is associated with the risk of severe sepsis | humans | PBMCs | 226 | 237 |
| miR-146a | down | – | humans | plasma | 14 + 14 (SIRS) | 238 |
| miR-499-5p | down | – | humans | serum | 166 | 26 |
| miR-122 | down | – | humans | serum | 166 | 26 |
| miR-193b | down | – | humans | serum | 166 | 26 |
| miR-150 | down | – | humans | PBMCs | 23 + 22 | 29 |
| miR-342 | down | – | humans | PBMCs | 23 + 22 | 29 |
| miR-3173-5p | down | – | humans | PBMCs | 23 + 22 | 29 |
| miR-181b | down | miR-181b regulates NF-κB-mediated endothelial cell activation and vascular inflammation in response to pro-inflammatory stimuli | in vitro | plasma | 26 SP | 139 |
| in vivo | 36 SP + ARDS | |||||
| let-7a | down | – | mice | lung | – | 239 |
| miR-129-5p | down | – | mice | lung | – | 239 |
| miR-218 | down | – | mice | lung | – | 239 |
| miR-21 | up | miR-21 is involved in the regulation of late sepsis | in vivo | blood | 33 | 235 |
| miR-155 | up | miR-155 induced an elevated percentage of CD39+ regulatory T cells, leading to immunosuppression | in vivo | blood | 60 | 97 |
| miR-15a | up | upregulated miR-15a downregulated the LPS-induced inflammatory pathway | humans | serum | 46 | 136 |
| miR-16 | up | upregulated miR-16 downregulated the LPS-induced inflammatory pathway | humans | serum | 46 | 136 |
| miR-15a | up | serum miR-15a/miR-16 levels were significantly elevated in sepsis/SIRS patients when compared to healthy controls | humans | serum | 166 + 32 | 27 |
| miR-16 | ||||||
| miR-574-5p | up | serum level was correlated with the death of sepsis patients | humans | serum | 142 | 103 |
| the combined analysis of miR-574-5p, SOFA scores, and the sepsis stage on the day of diagnosis provided a good predictor for sepsis prognosis | ||||||
| miR-297 | up | serum miR-297 level was higher in survivors than non-survivors among septic patients | humans | serum | 142 | 103 |
| miR-223 | up | – | humans | serum | 166 | 26 |
| miR-19a | up | – | in vitro | B cells | 38 + 26 (SIRS) | 240 |
| miR-486 | up | – | humans | plasma, leukocytes | 8 | 140 |
| miR-34a | up | – | humans | plasma | 62 | 30 |
| miR-145 | up | – | humans | PBMCs | 32 | 80 |
| miR-143 | up | – | humans | PBMCs | 32 | 80 |
| miR-182 | up | – | humans | PBMCs | 32 | 80 |
| miR-486 | up | – | humans | PBMCs | 32 | 80 |
| miR-1308 | up | – | humans | PBMCs | 32 | 80 |
| miR-4772 | up | – | humans | blood | 23 +22 | 29 |
| miR-143 | up | serum miR-143 levels were significantly higher in sepsis than in SIRS and healthy controls | humans | serum | 103 | 241 |
| 95 | ||||||
| miR-133a | up | there was a correlation between the levels of miR-133a and sepsis severity | humans, mice | serum | 138 | 137 |
| miR-4772 | up | – | humans | blood | 23 + 22 | 29 |
| let-7d | up | the levels of these biomarkers were elevated in whole blood after LPS injection | mice | blood, organs | – | 242 |
| miR-15b | up | the levels of these biomarkers were elevated in whole blood after LPS injection | mice | blood, organs | – | 242 |
| miR-16 | up | the levels of these biomarkers were elevated in whole blood after LPS injection | mice | blood, organs | – | 242 |
| miR-25 | up | the levels of these biomarkers were elevated in whole blood after LPS injection | mice | blood, organs | – | 242 |
| miR-92a | up | the levels of these biomarkers were elevated in whole blood after LPS injection | mice | blood, organs | – | 242 |
| miR-103 | up | the levels of these biomarkers were elevated in whole blood after LPS injection | mice | blood, organs | – | 242 |
| miR-107 | up | the levels of these biomarkers were elevated in whole blood after LPS injection | mice | blood, organs | – | 242 |
| miR-451 | up | the levels of these biomarkers were elevated in whole blood after LPS injection | mice | blood, organs | – | 242 |
| miR-15a | up | the levels of these biomarkers were elevated in lung | mice | blood, organs | – | 242 |
| miR-16 | up | the levels of these biomarkers were elevated in lung | mice | blood, organs | – | 242 |
| miR-21 | up | the levels of these biomarkers were elevated in lung | mice | blood, organs | – | 242 |
| miR-146a | up | the levels of these biomarkers were elevated in lung | mice | blood, organs | – | 242 |
| miR-155 | up | the levels of these biomarkers were elevated in lung | mice | blood, organs | – | 242 |
| miR-223 | up | the levels of these biomarkers were elevated in lung | mice | blood, organs | – | 242 |
| miR-195 | up | miR-195 was elevated in lung and liver of sepsis-induced mice | mice | lung, liver | – | 7 |
| miR-27a | up | miR-27a induces an inflammatory response in sepsis | mice | lung | – | 239 |
| miR-143 | up | mice | lung | – | 239 | |
| miR-153 | up | mice | lung | – | 239 | |
| miR-21 | up | miR-21 increased in early sepsis and showed a sustained increase until late sepsis | mice | bone marrow | – | 96 |
| miR-181b | up | miR-181b increased in early sepsis and showed a sustained increase until late sepsis | mice | bone marrow | – | 96 |
| miR-16 | up | miRNAs upregulated after CLP | mice | blood | – | 243 |
| miR-17 | up | miRNAs upregulated after CLP | mice | blood | – | 243 |
| miR-20a/b | up | miRNAs upregulated after CLP | mice | blood | – | 243 |
| miR-26a/b | up | miRNAs upregulated after CLP | mice | blood | – | 243 |
| miR-106a/b | up | miRNAs upregulated after CLP | mice | blood | – | 243 |
| miR-195 | up | miRNAs upregulated after CLP | mice | blood | – | 243 |
| miR-451 | up | miRNAs upregulated after CLP | mice | blood | – | 243 |
| miR-29a | – | miR-29a induces apoptosis of monocytes via targeting STAT3 during sepsis | mice | THP-1 cells | – | 101 |
| miR-30a | – | miR-30a inhibits MD-2 expression by targeting STAT1 in human monocytes | mice | THP-1 cells | – | 244 |
| miR-146 | – | the transfection of miR-146a reduces the sepsis-induced cardiac dysfunction through inhibiting inflammatory cell infiltration, NF-κB activation, and inflammatory cytokine production by targeting TRAF6 and IRAK | mice | H9C2 and J774 cells | – | 83 |
| miR-150 | – | reduced miR-150 serum concentrations are associated with an unfavorable outcome in patients with critical illness, independent of the presence of sepsis | humans | serum | 138 | 42 |
| miR-223 | – | it has been found that this biomarker does not appropriate in predicting sepsis | humans, mice | serum | 137 | 43 |
| miR-122 | – | serum miR-122 levels correlated with short-term mortality in sepsis patients and are a potential biomarker for sepsis and ARDS | humans | serum | 232 | 104 |
| miR-15a | – | the expression levels of miR-193b, miR-122, miR-483-5p, and miR-15a in the sepsis non-survivors were significantly higher than those in the sepsis survivors, and the levels of miR-223 and miR-16 were significantly lower | humans | serum | 214 | 245 |
| miR-16 | ||||||
| miR-122 | ||||||
| miR-193b | ||||||
| miR-483-5p | ||||||
| miR-223 |